✦ LIBER ✦

Site-specific recombinases in genetic engineering: Modern in vivo technologies

✍ Scribed by B. Ostash

Book ID: 111495793
Publisher: Allerton Press Inc
Year: 2010
Tongue: Ukrainian
Weight: 197 KB
Volume: 44
Category: Article
ISSN: 0095-4527
DOI: 10.3103/s0095452710040109

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Site-specific recombination for genetic

Site-specific recombination for genetic engineering in plants

✍ L. A. Lyznik; W. J. Gordon-Kamm; Y. Tao 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 243 KB

Talking about a Revolution: The Impact o

Talking about a Revolution: The Impact of Site-Specific Recombinases on Genetic Analyses in Mice

✍ Catherine S. Branda; Susan M. Dymecki 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 673 KB

When reverse genetics meets physiology:

When reverse genetics meets physiology: the use of site-specific recombinases in mice

✍ François Tronche; Emilio Casanova; Marc Turiault; Iman Sahly; Christoph Kellendo 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 393 KB

Genetic Engineering of Herpes Simplex Vi

Genetic Engineering of Herpes Simplex Virus and Vector Genomes Carrying loxP Sites in Cells Expressing Cre Recombinase

✍ Carine Logvinoff; Alberto L. Epstein 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 436 KB

[Topics in Current Genetics] Site-direct

[Topics in Current Genetics] Site-directed insertion of transgenes Volume 23 || Targeted Plasmid Integration into the Human Genome by Engineered Recombinases

✍ Renault, Sylvaine; Duchateau, Philippe 📂 Article 📅 2012 🏛 Springer Netherlands ⚖ 392 KB

In Vivo Determination of Substrate Speci

In Vivo Determination of Substrate Specificity of Hepatitis C Virus NS3 Protease: Genetic Assay for Site-Specific Proteolysis

✍ Sung Yun Kim; Kye Won Park; Yong Jae Lee; Sung Hoon Back; Jae Hwan Goo; Ohkmae K 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Hepatitis C virus (HCV) NS3 protease is responsible for the processing of the viral polyprotein and is considered as a primary target for the development of anti-HCV therapy. We have developed a genetic method in yeast to screen for good substrate sequences of the NS3 protease. A library of fusion p